'Green' silver nanoparticles combined with tyrosol as potential oral antimicrobial therapy

José Antonio Santos Souza,Jackeline Gallo do Amaral,Douglas Roberto Monteiro,Renan Aparecido Fernandes,Gabriela Lopes Fernandes,Luiz Fernando Gorup,Francisco Nunes de Souza Neto,Emerson Rodrigues de Camargo,Alessandra Marçal Agostinho,Debora Barros Barbosa,Alberto Carlos Botazzo Delbem
DOI: https://doi.org/10.1016/j.jdent.2024.104867
IF: 4.991
2024-01-29
Journal of Dentistry
Abstract:Objectives This study aimed to evaluate silver nanoparticles (AgNPs) obtained by a 'green' route associated or not to tyrosol (TYR) against Streptococcus mutans and Candida albicans in planktonic and biofilms states. Methods AgNPs were obtained by a 'green' route using pomegranate extract. The minimum inhibitory concentration (MIC) against S. mutans and C. albicans was determined for AgNPs and TYR combined and alone, and fractional inhibitory concentration index (FICI) was calculated. Single biofilms of C. albicans and S. mutans were cultivated for 24 h and then treated with drugs alone or in combination for 24 h. Results AgNPs and TYR were effective against C. albicans and S. mutans considering planktonic cells alone and combined. The MIC values obtained for C. albicans was 312.5 μg/mL (AgNPs) and 50 mM (TYR) and for S. mutans was 78.1 μg/mL (AgNPs) and 90 mM (TYR). The combination of these antimicrobial agents was also effective against both microorganisms: 2.44 μg/mL/0.08 mM (AgNPs/TYR) for C. albicans and 39.05 μg/mL /1.25 mM (AgNPs/TYR) for S. mutans . However, synergism was observed only for C. albicans (FICI 0.008) . When biofilm was evaluated, a reduction of 4.62 log 10 was observed for S. mutans biofilm cells treated with AgNPs (p 0.05). AgNPs combined with TYR demonstrated a synergistic effect against C. albicans biofilms. Conclusions These findings suggest the potential use of AgNPs with or without TYR against C. albicans and S. mutans, important oral pathogens. Clinical significance AgNPs obtained by a 'green' route combined or not with TYR can be an alternative to develop several types of oral antimicrobial therapies and biomaterials.
dentistry, oral surgery & medicine
What problem does this paper attempt to address?